Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Adenocarcinoma of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04543071
What this trial is testing

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerAdenocarcinoma of the PancreasAdenocarcinoma
Columbia University 118
Testing effectiveness (Phase 2)Study completedNCT00560963
What this trial is testing

Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine

Who this might be right for
Advanced or Metastatic Pancreatic Adenocarcinoma
Novartis Pharmaceuticals 21
Testing effectiveness (Phase 2)Study completedNCT03807999
What this trial is testing

Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer

Who this might be right for
Pancreatic Neoplasm
Hacettepe University 125
Testing effectiveness (Phase 2)Ended earlyNCT02202785
What this trial is testing

MLN0264 in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Millennium Pharmaceuticals, Inc. 43
Early research (Phase 1)Study completedNCT01155258
What this trial is testing

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Extensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more
University of Southern California 19
Testing effectiveness (Phase 2)Looking for participantsNCT06405490
What this trial is testing

NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC

Who this might be right for
Nanoliposomal IrinotecanCadonilimabOxaliplatin+5 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Not applicableUnknownNCT01919151
What this trial is testing

Micrometastasis in Gastrointestinal Cancer

Who this might be right for
Pancreatic AdenocarcinomaColorectal Cancer
Oslo University Hospital 500
Not applicableLooking for participantsNCT04907643
What this trial is testing

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Who this might be right for
Cancer PainVisceral PainGastrointestinal Neoplasms+76 more
Cedars-Sinai Medical Center 360
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Large-scale testing (Phase 3)UnknownNCT00075452
What this trial is testing

Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Study completedNCT00126633
What this trial is testing

Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of California, San Francisco 53
Testing effectiveness (Phase 2)Study completedNCT02504333
What this trial is testing

Phase I/II Study of Nab-paclitaxel and Gemcitabine Followed by AG-mFOLFOX in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 168
Testing effectiveness (Phase 2)WithdrawnNCT06592664
What this trial is testing

Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC

Who this might be right for
Pancreas CancerPancreatic CarcinomaPancreas Adenocarcinoma+5 more
Lisata Therapeutics, Inc.
Large-scale testing (Phase 3)UnknownNCT00486460
What this trial is testing

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tel-Aviv Sourasky Medical Center
Testing effectiveness (Phase 2)Study completedNCT00004910
What this trial is testing

Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction

Who this might be right for
Colorectal CancerConstipation, Impaction, and Bowel ObstructionExtrahepatic Bile Duct Cancer+6 more
Northwestern University
Testing effectiveness (Phase 2)Ended earlyNCT03490760
What this trial is testing

Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the Pancreas

Who this might be right for
Adenocarcinoma of the Pancreas
Baptist Health South Florida 9
Early research (Phase 1)Ended earlyNCT02132403
What this trial is testing

(PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Illinois at Chicago 3
Testing effectiveness (Phase 2)Study completedNCT01064622
What this trial is testing

Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage IV Pancreatic Cancer AJCC v6 and v7
National Cancer Institute (NCI) 118
Testing effectiveness (Phase 2)Study completedNCT00003951
What this trial is testing

DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Daiichi Sankyo 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT05249101
What this trial is testing

Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
CG Pharmaceuticals, Inc 70
Next Page